All Stories

  1. Clinical efficacy and safety of Zarzio® (EP2006), a biosimilar recombinant human granulocyte colony-stimulating factor

    Article • Biosimilars, March 2014, Taylor & Francis

    Dr Alaa Bagalagel

  2. Clinical efficacy and safety of SB309, a biosimilar recombinant human erythropoietin, in the management of anemia

    Article • Biosimilars, August 2013, Taylor & Francis

    Dr Alaa Bagalagel

  3. Clinical efficacy and safety of Tevagrastim® (XM02), a biosimilar recombinant human granulocyte colony-stimulating factor

    Article • Biosimilars, August 2013, Taylor & Francis

    Dr Alaa Bagalagel

  4. Clinical efficacy and safety of XM01, a biosimilar recombinant human erythropoietin, in the management of anemia

    Article • Biosimilars, August 2013, Taylor & Francis

    Dr Alaa Bagalagel

  5. Biosimilars in 3D

    Article • Bioengineered, July 2013, Taylor & Francis

    Dr Alaa Bagalagel, Ahmed Altyar

  6. Use Pattern of Oral PDE-5 Inhibitors in Jeddah, Saudi Arabia

    Article • Journal of King Abdulaziz University-Medical Sciences, January 2008, King Abdulaziz University Scientific Publishing Centre

    Dr Alaa Bagalagel